AstraZeneca
AZN
AZN
901 hedge funds and large institutions have $31.1B invested in AstraZeneca in 2021 Q3 according to their latest regulatory filings, with 193 funds opening new positions, 419 increasing their positions, 152 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
901
Holders Change
+135
Holders Change %
+17.62%
% of All Funds
15.82%
Holding in Top 10
17
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+54.55%
% of All Funds
0.3%
New
193
Increased
419
Reduced
152
Closed
49
Calls
$925M
Puts
$625M
Net Calls
+$299M
Net Calls Change
+$95.2M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$863M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$562M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$468M |
| 4 |
Renaissance Technologies
New York
|
+$401M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$329M |
Top Sellers
| 1 |
Citigroup
New York
|
-$679M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$227M |
| 3 |
Goldman Sachs
New York
|
-$187M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$111M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$65.7M |